APA (7th ed.) Citation

Liu, M. C., Pitcher, B. N., Mardis, E. R., Davies, S. R., Snider, J. E., Vickery, T., . . . Barry, W. T. (2012). PAM50 gene signature is prognostic for breast cancer patients treated with adjuvant anthracycline and taxane based chemotherapy. Cancer Research, 72(24a), 585. https://doi.org/10.1158/0008-5472.SABCS12-P2-10-01

Chicago Style (17th ed.) Citation

Liu, M. C., et al. "PAM50 Gene Signature Is Prognostic for Breast Cancer Patients Treated with Adjuvant Anthracycline and Taxane Based Chemotherapy." Cancer Research 72, no. 24a (2012): 585. https://doi.org/10.1158/0008-5472.SABCS12-P2-10-01.

MLA (9th ed.) Citation

Liu, M. C., et al. "PAM50 Gene Signature Is Prognostic for Breast Cancer Patients Treated with Adjuvant Anthracycline and Taxane Based Chemotherapy." Cancer Research, vol. 72, no. 24a, 2012, p. 585, https://doi.org/10.1158/0008-5472.SABCS12-P2-10-01.